The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 07, 2021
Filed:
May. 23, 2019
Applicant:
Amolyt Pharma, Ecully, FR;
Inventors:
Thomas Delale, Charbonnieres-les-Bains, FR;
Stephane Milano, Saint Nizier d'Azergues, FR;
Thierry Abribat, St-Foy-les-Lyon, FR;
David Clemmons, Chapel Hill, NC (US);
Assignee:
Amolyt Pharma, Ecully, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/655 (2006.01); A61P 3/10 (2006.01); A61P 3/04 (2006.01); C07K 7/64 (2006.01); C07K 14/47 (2006.01); C07K 7/52 (2006.01); A61K 47/60 (2017.01); A61K 38/17 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/655 (2013.01); A61K 38/1754 (2013.01); A61K 47/60 (2017.08); A61P 3/04 (2018.01); A61P 3/10 (2018.01); C07K 7/52 (2013.01); C07K 7/64 (2013.01); C07K 14/4743 (2013.01); A61K 38/00 (2013.01);
Abstract
The present technology generally relates to compounds, in particular peptides comprising the heparin-binding domain (HBD) of insulin-like growth factor binding protein-2 (IGFBP-2) for the modulation of metabolic disorders. The present technology also generally relates to uses of such compounds in methods for preventing and/or treating metabolic disorders and in compositions and formulations for such uses.